Abstract:
Starpharma Holdings has attracted respected investment company Biotech Capital plus a crew of institutional investors to its $7.56 million share placement, as the Melbourne-based drug developer gears up to expand its promising US nanotechnology subsidiary. The shares were placed with institutional clients of Michael Kroger's JT Campbell & Company, which acted as lead manager and placement agent. (more on earlier article)